our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 25 June 2014

    Rapid Restoration and Consistent Maintenance of Steady Blood Levels Achieved With Once-Weekly Subcutaneous Administration of Testosterone Delivered With a Novel Auto Injector
  • 24 June 2014

    Antares Pharma Announces Change in Senior Leadership
  • 28 May 2014

    Antares Pharma to Present at the Jefferies 2014 Global Healthcare Conference
  • 22 May 2014

    Antares Pharma Appoints Jennifer Evans Stacey ESQ., Senior Vice President , General Counsel, Human Resources and Secretary
  • 20 May 2014

    Antares Pharma Announces the Publication of Three Abstracts at the 2014 European League Against Rheumatism Annual Congress
  • 9 May 2014

    Antares Pharma Reports First Quarter 2014 Operating and Financial Results

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>